Growth at Reasonable Price
Results
5
1 new
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
DOV | €2.12 | -14.9% | -17.4% | €401.7m | €3.30 | 0.7 | 68.2% | 4.4% | Commercial Services | ||
ZV New | €7.03 | -6.8% | -16.4% | €620.5m | €8.70 | 19.1 | 20.4% | 3.1% | Materials | ||
FF | €8.24 | -7.0% | 3.3% | €193.8m | €13.06 | 28.1 | 32.3% | 1.9% | Pharmaceuticals & Biotech | ||
MFEB | €3.40 | -8.5% | -10.5% | €2.0b | €4.13 | 10.7 | 20.4% | 6.5% | Media | ||
REC | €51.35 | -0.1% | -4.3% | €10.4b | €59.06 | 22.1 | 15.2% | 2.6% | Pharmaceuticals & Biotech |
Page 1 of 1